Alteration of hepatic cells glucose metabolism as a non-cholinergic detoxication mechanism in counteracting diazinon-induced oxidative stress

Human and Experimental Toxicology

Volumn 25, Issue 12, 2006, Pages 697-703

  Teimouri, Fatemeh ^a   Amirkabirian, Nasim ^a   Esmaily, Hadi ^a   Mohammadirad, Azadeh ^a   Aliahmadi, Atousa ^a   Abdollahi, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cell; Diazinon; Gluconeogenesis; Glucose; Glycogenolysis; Lipid peroxidation; Liver; Rat; Total antioxidant capacity

Indexed keywords

DIMPYLATE; GLUCOSE; GLYCOGEN PHOSPHORYLASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DETOXIFICATION; DISORDERS OF CARBOHYDRATE METABOLISM; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCOGENOLYSIS; LIPID PEROXIDATION; LIVER CELL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD GLUCOSE; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; DIAZINON; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCONEOGENESIS; GLYCOGEN PHOSPHORYLASE, LIVER FORM; GLYCOGENOLYSIS; INSECTICIDES; LIPID PEROXIDATION; LIVER; MALE; OXIDATIVE STRESS; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

RATTUS;

EID: 33846217384     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327106075064     Document Type: Article

References (47)

1. Barr DB, Bravo R, Weerasekera G, Caltabiano LM, Whitehead RD Jr, Olsson AO, Caudill SP, Schober SE, Pirkle JL, Sampson EJ, Jackson RJ, Needham LL. Concentrations of dialkyl phosphate metabolites of organophosphorus pesticides in the U.S. population. Environ Health Perspect 2004; 112: 186-200.
2. Casida JE, Quistad GB. Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem Res Toxicol 2004; 17: 983-98. Review.
3. Abdollahi M, Jafari A, Jalali N. Chronic toxicity in organophosphate exposed workers. Med J Isl Rep Iran 1995; 9: 221-25.
4. Abdollahi M, Kebriaeezadeh A, Akhgari M, Pirdehghan F, Janat B, Jalali N. Cholinesterase levels in saliva, plasma and erythrocytes of Iranian population. Toxicol Lett 1995; 78: 15.
5. Abdollahi M, Jalali N, Sabzevari O, Hosseini R, Ghanea T. A retrospective study of poisoning in Tehran. J Toxicol Clin Toxicol 1997; 35: 387-93.
6. Jalali N, Pajoumand A, Abdollahi M, Shadnia S. Epidemiological survey of poisoning mortality in Tehran during 1997-1998. Toxicol Lett 2000; 116: P309.
7. Moghadamnia AA, Abdollahi M. An epidemiological study of poisoning in northern .Islamic Republic of Iran. East Mediterr Health J 2002; 8: 88-94.
8. Gupta RC. Toxicology of organophosphates and carbamate compounds. Elsevier Academic Press, 2006.
9. Neishabouri EZ, Hassan ZM, Azizi E, Ostad SN. Evaluation of immunotoxicity induced by diazinon in C57bl/6 mice. Toxicology 2004; 196: 173-79.
10. Akhgari M, Abdollahi M, Kebryaeezadeh A, Hosseini R, Sabzevari O. Biochemical evidence for free radical-induced lipid peroxidation as a mechanism for subchronic toxicity of malathion in blood and liver of rats. Hum Exp Toxicol 2003; 22: 205-11.
11. Pournourmohammadi S, Farzami B, Ostad SN, Azizi E, Abdollahi M. Effects of malathion subchronic exposure on rat skeletal muscle glucose metabolism. Environ Toxicol Pharmacol 2005; 19: 191-96.
12. Rodrigo L, Hernandez AF, Lopez-Caballero JJ, Gil F, Pla A. Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue, implications for its physiological role. Chem Biol Interact 2001; 137: 123-37.
13. Joshi SC, Mathur R, Gajraj A, Sharma T. Influence of methyl parathion on reproductive parameters in male rats. Environ Toxicol Pharmacol 2003; 14: 91-98.
14. Hagar HH, Fahmy AH. A biochemical, histochemical, and ultrastructural evaluation of the effect of dimethoate intoxication on rat pancreas. Toxicol Lett 2002; 133: 161-70.
15. de Blaquiere GE, Waters L, Blain PG, Williams FM. Electrophysiological and biochemical effects of single and multiple doses of the organophosphate diazinon in the mouse. Toxicol Appl Pharmacol 2000; 166: 81-91.
16. Shadnia S, Azizi E, Hosseini R, Khoei S, Fouladdel S, Pajoumand P, Jalali N, Abdollahi M. Evaluation of oxidative stress and genotoxicity in organophosphorus insecticide formulators. Hum Exp Toxicol 2005; 24: 439-45.
17. Abdollahi M, Ranjbar A, Shadnia S, Nikfar S, Rezaie A. Pesticides and oxidative stress: a review. Med Sci Monit 2004; 10: RA141-47.
18. Ranjbar A, Pasalar P, Abdollahi M. Induction of oxidative stress and acetylcholinesterase inhibition in organophosphorous pesticide manufacturing workers. Hum Exp Toxicol 2002; 21: 179-82.
19. Gupta RC, Milatovic D, Dettbarn WD. Depletion of energy metabolites following acetylcholinesterase inhibitor-induced status epilepticus: protection by antioxidants. Neurotoxicology 2001; 22: 271-82.
20. Kovacic P. Mechanism of organophosphates (nerve gases and pesticides) and antidotes: electron transfer and oxidative stress. Curr Med Chem 2003; 10: 2705-709.
21. Nakagawa Y, Moore G. Role of mitochondrial membrane permeability transition in p-hydroxybenzoate ester-induced cytotoxicity in rat hepatocytes. Biochem Pharmacol 1999; 58: 811-16.
22. Nordlie RC, Foster JD, Lange AJ. Regulation of glucose production by the liver. Annu Rev Nutr 1999; 19: 379-406.
23. Abdollahi M, Chan TS, Subrahmanyam V, O'Brien PJ. Effects of phosphodiesterase 3,4,5 inhibitors on hepatocyte cAMP levels, glycogenolysis, gluconeogenesis and susceptibility to a mitochondrial toxin. Mol Cell Biochem 2003; 252: 205-11.
24. Meller D, Fraser I, Kryger M. Hyperglycemia in anticholinesterase poisoning. Can Med J 1981; 124: 745-48.
25. Matin MA, Sattar S, Husain K. The role of adrenals in diazinon-induced changes in carbohydrate metabolism in rats. Arh Hig Rada Toksikol 1990; 41: 347-56.
26. Abdollahi M, Donyavi M, Pournourmohammadi S, Saadat M. Hyperglycemia associated with increased hepatic glycogen phosphorylase and phosphoenolpyruvate carboxykinase in rats following subchronic exposure to malathion. Comp Biochem Physiol C Toxicol Pharmacol 2004; 137: 343-47.
27. Panahi P, Vosough-Ghanbari S, Pournourmohammadi S, Ostad SN, Nikfar S, Minaie B, Abdollahi M. Stimulatory effects of malathion on the key enzymes activities of insulin secretion in Langerhans islets, glutamate dehydrogenase and glucokinase. Toxicol Mech Methods 2006; 16: 161-67.
28. Saadat M, Pournourmohammadi S, Donyavi M, Khorasani R, Amin G, Nazar Salehnia A, Abdollahi M. Alteration of rat hepatic glycogen phosphorylase and phosphoenolpyruvate carboxykinase activities by Satureja khuzestanica Jamzad essential oil. J Pharm Pharm Sci 2004; 7: 310-14.
29. Bergmeyer HU, Bernt E, Schmidt F, Stork H. D-glucose. In Bergmeyer HU ed. Methods of enzymatic analysis, Volume 3. Academic Press, 1974: 1196-201.
30. Ellman GL, Courtney KD, Andress V, Featherston RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95.
31. Chang HC, Lane MD. The enzymatic carboxylation of phosphoenolpyruvate. II. Purification and properties of liver mitochondrial phosphoenolpyruvate carboxykinase. J Biol Chem 1966; 241: 2413-20.
32. Lowry OH, Schulz DW, Passonneau JV. The kinetics of glycogen phosphorylases from brain and muscle. J Biol Chem 1967; 242: 271-80.
33. Lowry OH, Roserbrough NJ, Farr AL, Randell RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193: 265-75.
34. Bensi IF, Strains S. Ferric reducing antioxidant assay. Methods Enzymol 1999; 292: 15-27.
35. Satho K. Serum lipid peroxidation in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978; 90: 37-43.
36. Seifert J, Pewnim T. Alteration of mice L-tryptophan metabolism by the organophosphorous acid triester diazinon. Biochem Pharmacol 1992; 44: 2243-50.
37. Costa LG, Li WF, Richter RJ, Shih DM, Lusis AJ, Furlong CE. PON1 and organophosphate toxicity. In Costa L, Furlong CE eds. Paraoxonase (PON1) in health and disease: basic and clinical aspects. Kluwer Academic Publishers, 2002: 16.
38. Canales A, Sanchez-Muniz FJ. Paraoxonase, something more than an enzyme? Med Clin (Barc) 2003; 121: 537-48.
39. Ellenhorn MJ, Schonwald S, Ordog G, Wasserberger J. Ellenhorn's medical toxicology: diagnosis and treatment of human poisoning. Williams & Wilkins Co, 1997: 1614-63.
40. Mackness MI, Durrington PN, Mackness B. How high-density lipoprotein protects against the effects of lipid peroxidation. Curr Opin Lipidol 2000; 11: 383-88.
41. Mackness MI, Harty D, Bhatnagar D, Winocour PH, Arrol S, Ishola M, Durrington PN. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis 1991; 86: 193-99.
42. Patel BN, Mackness MI, Harty DW, Arrol S, Boot-Handford RP, Durrington PN. Serum esterase activities and hyperlipidaemia in the streptozotocin-diabetic rat. Biochim Biophys Acta 1990; 1035: 113-16.
43. Exton JH. Mechanisms of hormonal regulation of hepatic glucose metabolism. Diabetes Metab Rev 1987; 3: 163-83.
44. Rothman DL, Magnusson I, Cline G, Gerard D, Kahn CR, Shulman RG, Shulman GI. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 1995; 92: 983-87.
45. Abdollahi M, Soleimani F, Kangarlou S. A review on blood glucose variations and affecting parameters. Mid East Pharm 2003; 11: 6-10.
46. Akkus I, Kalak S, Vural H, Caglayan O, Meneke E, Can G, Durmus B. Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C concentrations of patients with type II diabetes mellitus. Clin Chim Acta 1996; 244: 221-27.
47. International Programme on Chemical Safety. Inventory of IPCS and other WHO pesticide evaluations and summary of toxicological evaluations performed by the JMPR, WHO/PCS/02.3. World Health Organization, 2003.